Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Towa Pharmaceutical Co Ltd

https://www.towayakuhin.co.jp/

Latest From Towa Pharmaceutical Co Ltd

Towa Snaps Up Sunsho For Value-Added Advantage

Towa Pharmaceutical has struck a deal to acquire fellow Japanese firm Sunsho Pharmaceutical in a move that Towa says will help it to diversify by developing value-added products.

Deals M & A

Towa Raises Japanese Expectations Amid Uncertain Business Climate

Towa has issued a minor upward revision to its full-year guidance after its domestic business delivered higher than expected sales and profit growth during H1, but uncertainty in the Japanese generics market and concerns over the firm’s overseas units have led some analysts to raise questions.

Sales & Earnings Japan

Towa Follows Suit With Sawai To Steal Japanese Share From Nichi-Iko

Japanese player Towa Pharmaceutical joined Sawai in capitalizing on Nichi-Iko’s misery by taking market share from its rival, as it ran factories at full capacity and plotted for further expansion.

Sales & Earnings Quality

Towa Aims To Restore Japanese Trust In Generics Quality

Japan’s Towa Pharmaceutical has published its fifth mid-term business plan, alongside financial results for the 12 months ended 31 March 2021.

Generic Drugs Quality
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
    • Generic Drugs
  • Other Names / Subsidiaries
    • J-Dolph Co., Ltd
UsernamePublicRestriction

Register